1. CAR-T Trial Eradicates Myeloma Cells in All 20 High-Risk Patients, Raising Hope for Cancer Prevention
A small but striking clinical trial has delivered results that could redefine the treatment of multiple myeloma. At the American Association for Cancer Research meeting, researchers reported that all 20 patients with high-risk smoldering multiple myeloma—a precursor to active cancer—had no detectable myeloma cells in t...